Retrospective Study
Copyright ©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 712-718
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.712
Table 1 Baseline characteristics
DDKT (n = 111)SCD (32)AKI (51)ECD (28)aP-valuebP-value
Recipients
Age year (mean ± SD)42.7 ± 13.843.9 ± 12.043.1 ± 12.30.680.67
Male n (%)19 (59.4)35 (68.6)16 (57.1)0.480.55
Pre KT dialysis11
Hemodialysis n (%)26 (81.3)42 (82.4)23 (82.1)
Peritoneal dialysis n (%)6 (18.8)9 (17.7)5 (17.9)
Comorbid n (%)
DM2 (6.25)8 (15.7)3 (10.7)0.30.48
HT30 (93.8)49 (96.1)25 (89.3)0.670.41
CAD1 (3.1)1 (1.9)1 (3.6)11
Cause of ESRD n (%)0.910.73
Unknown (no biopsy)23 (23.2)33 (31.8)18 (18.9)
Diabetic nephropathy1 (0.9)1 (1.3)1 (0.8)
IgA nephropathy1 (1.9)2 (2.6)3 (1.5)
Chronic glomerulonephritis2 (0.9)1 (1.3)0 (0.8)
Blood group n (%)0.140.38
A4 (12.5)13 (25.5)7 (25.0)
B13 (40.6)13 (25.5)7 (25.0)
AB4 (12.5)2 (3.9)3 (10.7)
O11 (34.4)23 (45.1)11 (39.3)
PRA - % median (range)0 (0.85)0 (0.0)0 (0.0)0.030.04
Second KT n (%)2 (6.25)3 (5.88)1 (3.57)11
Total HLA mismatch - (mean ± SD)2.5 (1.2)2.3 (1.1)2.1 (1.1)0.520.76
Donors
Age, year (mean ± SD)33.9 ± 14.841.0 ± 12.061.2 ± 7.00.02< 0.001
Male n (%)24 (75.0)44 (86.3)17 (60.7)0.250.04
Terminal serum creatinine (mg/dL) - median (range)0.91 (0.73, 1.13)2.22 (1.65, 3.20)1.28 (0.99, 2.70)< 0.001
Cold ischemic time, minute (mean ± SD)1099 ± 2911129 ± 2941261 ± 2420.650.5
Immunosuppressive drugs
Induction n (%)0.110.19
No16 (50.0)16 (31.4)9 (32.1)
ATG5 (15.6)11 (21.6)11 (39.3)
Simulect11 (34.4)24 (47.1)8 (28.6)
Maintenance n (%)0.050.005
Tacrolimus/mycophenolate/prednisolone16 (50.0)27 (52.9)13 (46.4)
Cyclosporin A/mycophenolate/prednisolone15 (46.8)16 (31.4)5 (17.9)
Cyclosporin A/everolimus/prednisolone07 (13.7)8 (28.6)
Everolimus/mycophenolate/prednisolone1 (3.1)00
Table 2 Transplantation outcomes
OutcomesSCD (32)AKI (51)ECD (28)aP-valuebP-value
Cr at discharge - mg/dL (mean ± SD)1.35 ± 0.511.70 ± 0.842.41 ± 1.000.04< 0.001
Cr at 1 yr - mg/dL (mean ± SD)1.35 ± 0.501.59 ± 0.752.64 ± 1.380.14< 0.001
Cr at 2 yr - mg/dL (mean ± SD)1.52 ± 0.631.68 ± 1.063.29 ± 2.120.47< 0.001
eGFR at discharge - mL/min (mean ± SD)64.1 ± 22.152.5 ± 22.935.5 ± 17.90.03< 0.001
eGFR at 1 yr - mL/min (mean ± SD)63.6 ± 19.956.6 ± 23.933.9 ± 17.30.19< 0.001
eGFR at 2 yr - mL/min (mean ± SD)58.6 ± 23.256.6 ± 24.529.9 ± 19.20.65< 0.001
DGF n (%)10 (31.2)29 (56.9)21 (77.8)0.030.001
Length of stay - d (mean ± SD)24.4 ± 8.331.1 ± 14.737.9 ± 15.30.020.002
Nephrectomy n (%)02 (3.9)2 (7.4)0.520.27
Acute rejection5 (15.7)10 (19.6)6 (27.4)0.700.8
ACR2 (6.3)6 (11.8)2 (7.1)
ABMR1 (3.1)3 (5.9)3 (10.7)
ACR + ABMR2 (6.3)1 (1.9)1 (3.6)
Graft loss n (%)003 (11.5)NS0.01
Death n (%)2 (6.3)3 (5.1)3 (10.7)0.630.57
CMV n (%)7 (5.2)6 (8.3)5 (4.5)0.230.46
BK virus nephropathy n (%)1 (3.1)3 (5.69)010.69
Table 3 Estimated glomerular filtration rate classified by acute kidney injury network stage
eGFR - mean ± SDSCD (n)(32)AKIN stage (n)
P-value
1 (18)2 (21)3 (12)
eGFR at discharge - mL/min64.1 ± 22.149.8 ± 20.757.1 ± 23.749.6 ± 27.20.87, 0.07
eGFR at 1 yr - mL/min63.6 ± 19.952.9 ± 21.257.1 ± 21.561.9 ± 29.00.47, 0.92
eGFR at 2 yr - mL/min58.6 ± 23.253.4 ± 24.354.0 ± 21.464.0 ± 29.40.79, 0.54
Table 4 Univariate and multivariate regression analysis of factors associated with the change of one-year estimated glomerular filtration rate
FactorsUnivariate
Multivariate
B-coefficientP-value95%CIB-coefficientP-value95%CI
Type of donor
SCDReferenceNAReferenceNA
AKI-6.730.17-16.41, 2.94-3.70.49-14.52, 7.13
ECD-29.76< 0.001-41.67, -17.85-25.43< 0.001-38.80, -12.05
PRA > 20%3.490.64-7.37, 14.343.620.53-7.82, 15.05
DGF12.30.0083.22, 21.396.170.18-2.91, 15.25
HLA mismatch ≥ 3-2.990.53-12.45, 6.46-7.120.11-15.77, 1.53
CIT > 24 h-14.720.03-27.99, -1.45-9.540.14-22.19, 3.12
Received Induction4.490.36-5.28, 14.251.80.72-8.09, 11.70